Apollo Ingredients disclosed deviation in rights issue fund utilization for Q4 FY26, filed under SEBI Regulation 32.
₹3 crore originally allocated for raw materials/working capital was used for advance lease payment instead.
Unutilized issue expense of ₹0.02 crore was reallocated to working capital with shareholder approval on 30-03-2026.
Audit Committee noted the deviation was shareholder-approved and in company's interest, with no auditor comments.